Showing results (2131-2140 of 2,317) with videos related to

Sort By:
Pageof 232
Cancer|June 23, 2017
Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trialFeng-Hua Wang, Yun Wang, Guo-Ping Sun, et al.
The New England Journal of Medicine|November 8, 2023
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLCDavid Planchard, Pasi A Jänne, Ying Cheng, et al.
Translational Lung Cancer Research|November 19, 2019
The impact of previous therapy strategy on the efficiency of anlotinib hydrochloride as a third-line treatment on patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis of ALTER0303 trialLili Wang, Zhen He, Sen Yang, et al.
JTO Clinical and Research Reports|October 11, 2022
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping AlterationsShun Lu, Jian Fang, Xingya Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Safety but Limited Efficacy of Ensartinib in ROS1-Positive NSCLC: A Single-Arm, Multicenter Phase 2 StudyXinghao Ai, Qiming Wang, Ying Cheng, et al.
Zhonghua Yi Xue Za Zhi|October 29, 2010
[A pilot study of weekly versus 3-week docetaxel in combination with capecitabine in patients with anthracycline-pretreated metastatic breast cancer]Shao-hua Zhang, Ze-fei Jiang, Xiao-dong Xie, et al.
Med (New York, N.Y.)|June 13, 2024
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trialZi-Xian Wang, Junjie Peng, Xinjun Liang, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II studyJin-Ji Yang, Cheng Huang, Yun Fan, et al.
Cell Stem Cell|October 22, 2021
Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell functionRong Yin, Jiwei Chang, Yashu Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 29, 2009
[Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study]Bing Hu, Ji-Ren Yu, Zhao-Zhang Wen, et al.
Pageof 232